Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases

被引：10

作者：

Ono, Masanori ^{[1
]}

Matsumoto, Kimikazu ^{[2
]}

Boku, Narikazu ^{[3
]}

Fujii, Nobuharu ^{[4
]}

Tsuchida, Yumi ^{[5
]}

Furui, Tatsuro ^{[6
]}

Harada, Miyuki ^{[7
]}

Kanda, Yoshinobu ^{[8
]}

Kawai, Akira ^{[9
]}

Miyachi, Mitsuru ^{[10
]}

Murashima, Atsuko ^{[11
]}

Nakayama, Robert ^{[12
]}

Nishiyama, Hiroyuki ^{[13
,14
]}

Shimizu, Chikako ^{[15
]}

Sugiyama, Kazuhiko ^{[16
,17
]}

Takai, Yasushi ^{[18
]}

Fujio, Keishi ^{[5
]}

Morishige, Ken-Ichirou ^{[6
]}

Osuga, Yutaka ^{[7
]}

Suzuki, Nao ^{[19
]}

机构：

[1] Tokyo Med Univ, Dept Obstet & Gynecol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan

[2] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan

[3] Natl Canc Ctr, Div Gastrointestinal Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan

[4] Okayama Univ Hosp, Div Blood Transfus, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan

[5] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan

[6] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, 1-1 Yanagido, Gifu, Gifu 5011194, Japan

[7] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan

[8] Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan

[9] Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan

[10] Kyoto Prefectural Univ Med, Dept Pediat, Kamigyo Ku, 465 Kajii Cho, Kyoto, Kyoto 6028566, Japan

[11] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Div Maternal Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan

[12] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan

[13] Univ Tsukuba, Fac Med, Dept Urol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan

[14] Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan

[15] Natl Ctr Global Hlth & Med Hosp, Dept Oncol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan

[16] Hiroshima Univ Hosp, Dept Clin Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan

[17] Hiroshima Univ Hosp, Neurooncol Program, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan

[18] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan

[19] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan

来源：

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 27卷 / 02期

基金：

日本学术振兴会;

关键词：

Fertility preservation; Cyclophosphamide; Pediatric; adolescent; and young adults with cancer; Oncofertility; Japan Society of Clinical Oncology; Japan Society for Fertility Preservation; STEM-CELL TRANSPLANTATION; OPEN-LABEL; MANAGEMENT; CYCLOPHOSPHAMIDE; RECOMMENDATIONS; MANIFESTATIONS; MULTICENTER; CHILDHOOD; DENOSUMAB; PREGNANCY;

D O I：

10.1007/s10147-021-02082-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, local governments in Japan have established a public financial support system for fertility preservation in pediatric, adolescent, and young adult cancer patients. Fertility preservation has become popular for patients with cancers included in the gonadal toxicity risk classification of the 2017 edition of the Guideline for Fertility Preservation in Children, Adolescents and Young Adult Cancer Patients from the Japan Society of Clinical Oncology. However, patients with cancer and non-cancer diseases that are not included in the Guideline's gonadal toxicity risk classification also often receive treatment that may affect fertility, but they are often denied the opportunity of fertility preservation because no public financial support is available for diseases not listed in the Guideline. The national research project proposes including these diseases in the indications and treatment for fertility preservation. Therefore, we cooperated with the Japan Society for Fertility Preservation and the Ministry of Health, Labour and Welfare research group to solicit opinions from experts in each therapeutic area and reviewed the literature and overseas guidelines. This paper summarizes the findings of the project. We believe that it will be an important source of information for clinicians treating patients who need fertility preservation but note that the appropriateness of fertility preservation for the disorders listed in this report needs to be continuously reviewed as medical care advances.

引用

页码：301 / 309

页数：9

共 47 条

[1] Pazopanib therapy for desmoid tumors in adolescent and young adult patients [J].

Agresta, Laura ;

Kim, Hee ;

Turpin, Brian K. ;

Nagarajan, Rajaram ;

Plemmons, Alexandra ;

Szabo, Sara ;

Dasgupta, Roshni ;

Sorger, Joel I. ;

Pressey, Joseph G. .

PEDIATRIC BLOOD & CANCER, 2018, 65 (06)

[2] EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome [J].

Andreoli, L. ;

Bertsias, G. K. ;

Agmon-Levin, N. ;

Brown, S. ;

Cervera, R. ;

Costedoat-Chalumeau, N. ;

Doria, A. ;

Fischer-Betz, R. ;

Forger, F. ;

Moraes-Fontes, M. F. ;

Khamashta, M. ;

King, J. ;

Lojacono, A. ;

Marchiori, F. ;

Meroni, P. L. ;

Mosca, M. ;

Motta, M. ;

Ostensen, M. ;

Pamfil, C. ;

Raio, L. ;

Schneider, M. ;

Svenungsson, E. ;

Tektonidou, M. ;

Yavuz, S. ;

Boumpas, D. ;

Tincani, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) :476-485

[3] ASCO Recommendations on Fertility Preservation in Cancer Patients: Guideline Summary [J].

不详 .

JOURNAL OF ONCOLOGY PRACTICE, 2006, 2 (03) :143-146

[4]

[Anonymous], 2018, SOLTAMOX TAMOXIFEN C

[5]

[Anonymous], 2019, ENHERTU FAM TRASTUZU

[6]

[Anonymous], 2012, PERJETATM PERTUZUMAB

[7] Neoadjuvant and Adjuvant Therapies for Breast Cancer [J].

Apuri, Susmitha .

SOUTHERN MEDICAL JOURNAL, 2017, 110 (10) :638-642

[8] Diagnostic criteria, severity classification and guidelines of systemic sclerosis [J].

Asano, Yoshihide ;

Jinnin, Masatoshi ;

Kawaguchi, Yasushi ;

Kuwana, Masataka ;

Goto, Daisuke ;

Sato, Shinichi ;

Takehara, Kazuhiko ;

Hatano, Masaru ;

Fujimoto, Manabu ;

Mugii, Naoki ;

Ihn, Hironobu .

JOURNAL OF DERMATOLOGY, 2018, 45 (06) :633-691

[9]

Azzarelli A, 2001, CANCER, V92, P1259, DOI 10.1002/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO

[10]

2-Y

← 1 2 3 4 5 →